HeartWare International, Inc. (NASDAQ: HTWR) today announced the conclusion of patient enrollment under its "ADVANCE" clinical trial.

This article: 375 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE